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Abstract
Identifying higher brain central region(s) that are responsible for the unpleasantness of pain is the
focus of many recent studies. Here we show that direct stimulation of the anterior cingulate cortex
(ACC) in mice produced fear-like freezing responses and induced long-term fear memory, including
contextual and auditory fear memory. Auditory fear memory required the activation of N-methyl-
D-aspartate (NMDA) receptors in the amygdala. To test the hypothesis that neuronal activity in
the ACC contributes to unpleasantness, we injected a GABAA  receptor agonist, muscimol
bilaterally into the ACC. Both contextual and auditory memories induced by foot shock were
blocked. Furthermore, activation of metabotropic glutamate receptors in the ACC enhanced
behavioral escape responses in a noxious hot-plate as well as spinal nociceptive tail-flick reflex. Our
results provide strong evidence that the excitatory activity in the ACC contribute to pain-related
fear memory as well as descending facilitatory modulation of spinal nociception.
Background
Pain in humans is an unpleasant sensory and emotional
experience associated with actual or potential tissue dam-
age, or described in terms of such damage [1]. The pain
experience contains at least two major components: the
first is the encoding and perception of sensory noxious
stimulus (e.g., pain intensity); and the second is the
encoding of the unpleasantness of the noxious stimuli
[2,3]. Exploration of the centers for pain-related unpleas-
antness has recently been carried out in human studies
using modern imaging techniques [4-8]. Among many
central regions investigated, the anterior cingulate cortex
(ACC) is believed to be a key structure that contributes to
pain affect or unpleasantness. Early human observations
showed that surgical ablation of the ACC significantly
reduced pain unpleasantness without influencing the
ability to detect the intensity or location of the pain
[9,10]. Rainelle et al [5] reported that specific manipula-
tion of pain unpleasantness produced significant changes
in the imaged activity of the ACC, while the manipulation
of pain intensity produced changes mainly in the primary
somatosensory cortex (S1) [2,5]. More recently, electro-
physiological recordings from the ACC in humans found
that some ACC neurons respond to noxious stimuli [6].
More interestingly, a recent study reported that the ACC
was also activated during social exclusion [11]. In addi-
tion to pain, the ACC has been proposed as the neurobio-
logical substrate for executive control of cognitive and
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motor processes [12]. Human imaging studies demon-
strate that the ACC region is activated by different factors
including motivational drive, reward, gain or loss, con-
flict-monitoring or error prediction, and attention or
anticipation [13-23]. The neuronal mechanisms for these
different functions within the ACC remain mostly
unknown due to the limitation of human studies.
Studies from our group and other investigators, using ani-
mal models, provide evidence for the importance of the
ACC in behavioural responses related to noxious stimuli
[24-32] and the "top-down" descending modulatory
effects [33]. Lesion in the medial frontal cortex, including
the ACC, significantly reduced the behavioral response to
noxious stimuli and aversive memory behaviors [24-26].
Also, electrophysiological recordings demonstrate that
neurons within the ACC respond to noxious stimuli
[6,28]. Tissue injury or digit amputation activates imme-
diate early gene expression and triggers long-term poten-
tiation of evoked sensory responses in the ACC [27-29]. In
mice genetically modified to over express NMDA NR2B
receptors in forebrain areas, including the ACC, behavio-
ral responses to tissue inflammation were significantly
enhanced [29]. Behavioural allodynia related to inflam-
mation was reduced by injection of antagonists of NMDA
receptors or inhibitors of cAMP-dependent protein
kinases [30,32]. These findings indicate that ACC neurons
are clearly involved in the processing of noxious stimuli,
and demonstrate activity-dependent long-term plasticity
in the ACC after tissue injury. In addition, ACC can also
serve as a "top-down" descending modulatory system that
regulates spinal nociceptive reflexes. Electrical stimulation
or chemical injection of glutamate receptor agonists facil-
itated a spinal nociceptive tail-flick reflex through a
descending facilitatory system relayed to the brainstem
rostral ventromedial medulla (RVM) [33-37].
It is difficult to distinguish the role of the ACC in pain-
related unpleasantness from its descending pain modula-
tory effects on sensory transmission in the spinal cord by
using behavioral withdrawal responses to noxious stim-
uli. A recent human imaging study reported that the ACC
is activated during placebo analgesia [7]. These results
suggest that the ACC may also play roles in placebo anal-
gesia. While the physiological nature of the imaged 'hot'
spots (i.e., excitation of excitatory versus inhibitory neu-
rons) remains to be determined, it has been proposed that
the ACC may activate endogenous analgesia systems due
to its projections to the periaqueductal gray (PAG) in the
midbrain [7,38].
Here we propose that the ACC serves as a region for pain
unpleasantness in the brain, and excitation of neurons in
the ACC can trigger pain unpleasantness but not analge-
sia. Because animals will never report human-like
'unpleasantness', we used a classic Pavlovian fear memory
to measure the effects of stimulation in the ACC. Our
operational definition of 'unpleasantness' in mice is based
on the formation of fear memory. If ACC stimulation trig-
gers 'unpleasantness' in mice, we expect to observe behav-
ioural freezing responses in mice receiving paired but not
unpaired fear-conditioning training. Another obvious
advantage of using the Pavlovian fear memory model is to
avoid using behavioural withdrawal responses (e.g., hind
paws or tail) that are constantly under descending inhibi-
tory and facilitatory modulatory influences. Experiments
were performed in both mice and rats to test the
hypothesis.
Results
We employed direct focal electrical stimulation of the
ACC in freely moving adult mice and used fear memory to
test if the ACC encodes for pain-related unpleasantness.
Animals were implanted with stimulating electrodes in
the ACC, and behavioural measurements were performed
at least 2 weeks after the surgery. Mice were placed in a
specially designed sound insulated chamber. After at least
30 min of baseline observation, a brief electrical current
was delivered to the ACC through the implanted elec-
trodes. We monitored ultrasonic activity, another index of
emotional responses [39], in some of the mice through-
out the experiments. Ultrasonic responses were increased
during ACC stimulation at 0.3 mA (n = 6 mice; P <0.05 as
compared with stimulation at 0 mA; see Fig. 1). Signifi-
cant changes were detected for both the frequency and
duration of ultravocalization events (Fig. 1b and 1c). The
ultrasonic activity induced by electrical stimulation was
intensity dependent. Stimulation at 0.01 mA produced
almost no significant changes, while stimulation at 1.0
mA induced greater responses (n = 6 mice, P <0.01 as
compared with stimulation at 0.1 or 0.3 mA; Fig. 1d).
Ultrasonic activity was found mostly between 30–50 kHz.
This frequency range of ultrasonic activity was also
increased by a noxious foot shock and by a painful chem-
ical injection of capsaicin. No obvious changes in motor
activity or seizure-like activity were found in mice after
receiving the focal ACC stimulation.
Next, we wanted to test if the fear-like freezing responses
induced by ACC stimulation were due to unpleasantness
(similar to that caused by a noxious foot shock). If so, we
would expect to see long-term fear memory induced by
ACC stimulation. We paired ACC electrical stimulation
with a tone presented in a conditioning chamber (see Fig.
2a). After pairing ACC stimulation with the tone, long-
term fear memory was detected in most of the mice (n =
16 of 21 mice; 76.2%), both to the tone presentation in a
novel context (auditory memory) (Fig. 2b) and to the con-
ditioning environment (contextual memory) (Fig. 2c). In
the other animals, there is no specific freezing either to theMolecular Pain 2005, 1:6 http://www.molecularpain.com/content/1/1/6
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ACC stimulation induces ultrasonic vocalization in freely moving mice Figure 1
ACC stimulation induces ultrasonic vocalization in freely moving mice. (a) An example of ultrasonic responses from 
a single mouse at four different frequencies before, during and after ACC stimulation (at 0.3 mA). 1 min duration; see filled cir-
cle for the stimulation site within the ACC in (e); (b) ACC stimulation (0.3 mA; n = 6) increased the frequency of individual 
ultrasonic responses; * P <0.05, comparing the frequency during ACC stimulation with baseline response before the stimula-
tion; (c) ACC stimulation (0.3 mA; n = 6) also increased the duration of single ultrasonic response; * P < 0.05, comparing the 
duration during ACC stimulation with baseline duration before the stimulation; (d) Summarized data of ACC stimulation (n = 
6) produced ultrasonic responses at different intensities. Total vocalization responses (sec) within 2 min ACC stimulation were 
plotted against the intensity of stimulation; (e) Stimulating sites in ACC on the schematic representation of coronal section 
0.62 mm anterior to the Bregma. Filled circle, for data shown in (a); open circles, other sites for data shown in (b-d).Molecular Pain 2005, 1:6 http://www.molecularpain.com/content/1/1/6
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ACC stimulation induces long-term fear memory Figure 2
ACC stimulation induces long-term fear memory. (a) Three pairings of 30 s tone and 10 s electrical train stimulation 
were delivered in the paired group on the conditioning day; (b,c) Percentage freezing to the tone (b) and the conditioning con-
text (c) measured at 1 hr, 1 day and 3 days after paired training. After paired training, long-lasting fear memory was detected in 
most of the mice (n = 16 mice, filled circles), while some other mice showed no freezing across the test periods (n = 5, data 
not shown). After unpaired training of tone and ACC stimulation, mice showed no freezing to the tone (n = 6, open squares) 
but clear memory to the training environment; * P < 0.05 compared with the unpaired group;(d) Stimulating sites in ACC on 
the schematic representation of coronal section 0.62 mm anterior to the Bregma. Filled circles, effect sites of ACC paired 
group; open circles, no effect sites of ACC paired group; open squares, ACC unpaired group.Molecular Pain 2005, 1:6 http://www.molecularpain.com/content/1/1/6
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conditioning context or to the tone (Fig. 2d; n = 5 mice).
We did not find any clear anatomic separation between
effective versus ineffective stimulation sites in the ACC for
producing fear memory (Fig. 2d). There are two possible
explanations for this result. One is that some of sites may
have a higher stimulation threshold for inducing fear
memory. Alternatively, ACC neurons are functionally het-
erogeneous and some sites within the ACC do not con-
tribute to the unpleasantness of pain.
Pavlovian fear memory occurs when a subject learns to
associate a certain conditioned stimulus (CS) or cue with
a noxious unconditioned stimulus (US) [40-43]. To deter-
mine whether ACC stimulation-induced fear memory
results from association between the tone and ACC stim-
ulation, we performed experiments where the tone and
ACC stimulation were applied but unpaired in another
group of animals (Fig. 2b–c). We predicted that while sim-
ilar contextual memory may form (since animals received
the same amount of ACC stimulation in the same envi-
ronment), auditory memory, which requires the precise
pairing of US-CS, would be blocked. Indeed, mice receiv-
ing unpaired training demonstrated clear freezing
response in the conditioning context (n = 6 mice; P < 0.05
versus baseline responses), whereas no freezing response
was observed during tone presentation in the novel con-
text (P > 0.05, comparing behavioral responses before and
during the tone; Fig. 2b-–c).
Glutamate receptors including metabotropic glutamate
receptors (mGluRs) are found in the ACC [33,38]. To fur-
ther determine if local activation of glutamate receptors in
the ACC may also trigger similar responses as focal electri-
cal stimulation, we performed microinjection of a mGluR
agonist tACPD (0.25 µg in 0.5 µl) [33]. Microinjection of
tACPD into the ACC produced freezing responses within
10 min, indicating that activation of ACC neurons
induced freezing responses (n = 5 mice). Furthermore, we
also paired the tACPD microinjection with a tone (see Fig.
3a) to test if tACPD application with tone may also cause
fear memory. We measured fear responses at one and
three days the conditioning. We found that tACPD micro-
injection pairing produced significant behavioral freezing
responses at one and three days later (n = 5 mice; Fig. 3b
and 3c). Mice receiving the tACPD microinjection in the
ACC did not cause any visible abnormal motor hyperac-
tivity or seizure-like behaviors, although we cannot com-
pletely rule out other sub-threshold changes caused by the
microinjection.
Next, we asked whether stimulation-induced unpleasant-
ness is regional selective. If ACC activation is specifically
involved in fear conditioning, electrical stimulation out-
side of the ACC would not produce similar results. To test
this possibility, stimulating electrodes were implanted
into the primary somatosensory cortex (S1). It has been
well documented that somatosensory cortex contributes
to the central processing of sensory inputs, including pain
intensity (e.g., noxious stimulus parameters) [44]. As
shown in Fig. 4, this group of mice did not form fear
memory, even though they underwent exactly the same
conditioning procedures as the paired groups (P > 0.05
versus baseline; n = 5 mice).
Amygdala and its related structures are well known for the
induction of fear memory [40-43]. While the prefrontal
cortex has been recently implicated for its involvement in
the extinction of fear memory [45-47], it has not been
shown that ACC inputs to the amygdala may contribute to
the formation of fear memory. To test if fear-like long-
term memory induced by ACC conditioning requires the
involvement of amygdala, we selectively blocked the
NMDA receptors during training (ACC stimulation paired
with the environment or a tone). The NMDA receptors are
known to be important for the induction of fear memory
[48,49]. We implanted additional guide cannulas into the
basolateral amygdaloid complex (BLAC) for the microin-
jection of drugs (Fig. 5c). Before conditioning, the NMDA
receptor antagonist AP-5, was injected bilaterally into the
BLAC. At 15 min later, ACC stimulation was paired with
the tone presentation. For the control group, the same vol-
ume of saline was injected. As showed in Fig. 5a, AP-5 sig-
nificantly reduced ACC stimulation-induced fear memory
to the tone 1 day after conditioning (P < 0.05 versus saline
injected group; n = 5 mice), indicating that the NMDA
receptor function in the amygdala is required for the
formation of auditory fear memory. Importantly, the con-
textual memory was not affected (n = 5 mice; Fig. 5a), sup-
porting the notion that other structures such as the
hippocampus may contribute to contextual fear memory.
These results suggest that ACC stimulation produces
unpleasantness in mice and form fear auditory memory
through its interaction with the amygdala. Both animal
and human studies indicate that neurons in the ACC
respond to peripheral painful stimuli [6,28,50], and
injury triggers the activation of immediate early genes in
the ACC [27,29]. Unlike the somatosensory cortex, neu-
rons in the ACC have wide diffuse receptive fields, and
often contain the whole body of an animal, supporting its
role in coding unpleasantness of pain [6,51,52]. Support-
ing this hypothesis, lesions of the ACC or inhibition of
excitatory synaptic transmission in the ACC produces
antinociceptive effects or analgesia [24,25] and block for-
malin-induced conditioned place avoidance [26]. These
results argue that activation of the ACC or increased the
excitatory activity within the ACC is unpleasant or pain-
ful, acting directly or indirectly through other related
brain regions. However, a recent imaging study reported
that the activity in the ACC was increased during placeboMolecular Pain 2005, 1:6 http://www.molecularpain.com/content/1/1/6
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Activation of metabotropic glutamate receptors in the ACC caused long-term fear memory Figure 3
Activation of metabotropic glutamate receptors in the ACC caused long-term fear memory. (a) ACC tACPD 
microinjection (0.25 µg in 0.5 µl; indicated by an arrow) was paired with a tone (indicated by filled bar) on the conditioning day; 
(b, c) Percentage freezing to the tone (b) and the conditioning context (c) measured at 1 day and 3 days after paired training 
(n = 5 mice). *P < 0.05 compared with the control. (d) The sites in the ACC for tACPD microinjection on the schematic rep-
resentation of coronal section 0.62 mm anterior to the Bregma.Molecular Pain 2005, 1:6 http://www.molecularpain.com/content/1/1/6
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Primary somatosensory cortex (S1) stimulation produces no  long-term fear memory Figure 4
Primary somatosensory cortex (S1) stimulation pro-
duces no long-term fear memory. (a, b) Three pairings 
of 30 s tone and 10 s electrical train stimulation were deliv-
ered to somatosensory cortex (S1) caused neither long-term 
auditory (a) nor contextual memory (b) (n = 5). (c) Sites for 
stimulation in the S1.
NMDA receptors in the amygdala is required for auditory  fear memory induced by ACC stimulation Figure 5
NMDA receptors in the amygdala is required for 
auditory fear memory induced by ACC stimulation. 
(a) Bilateral microinfusions of AP-5 (2 µg/µl, 0.5 µl/side) in 
the BLAC 15 min before conditioning impaired auditory fear 
memory but no effect on contexual fear memory when 
tested 1 day later. Filled bars, AP-5 group (n = 5); open bars, 
saline group (n = 4). * P < 0.05 compared with saline-injected 
group. (b) Stimulation sites in ACC. Filled circles, AP-5 
group; open circles, saline group. (c) Microinjection sites in 
the BLAC on the schematic representation of coronal sec-
tion 1.94 mm posterior to the Bregma. Filled circles, AP-5 
group; open circles, saline group.Molecular Pain 2005, 1:6 http://www.molecularpain.com/content/1/1/6
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analgesia [7]. We think that the activation of endogenous
analgesia system is unlikely to account for placebo analge-
sia. Previous studies showed that stimulation of ACC did
not trigger the endogenous analgesia system [33]. Rather,
we propose that enhanced inhibitory activity may contrib-
ute to the placebo effects. To test if increasing inhibitory
transmission in the ACC may relieve unpleasantness due
to foot shock, we microinjected a GABAA receptor agonist,
muscimol into the ACC prior to the fear conditioning.
Muscimol significantly reduced the fear memory score 1
day and 3 days after classical fear conditioning (P < 0.05
versus saline injected group, n = 6 mice for each group)
(Fig. 6a–c).
One possible explanation is that activation of ACC neu-
rons is aversive in the absence of peripheral noxious stim-
uli, and is antinociceptive in case of peripheral noxious
stimuli. To test this possibility, we decided to test if activa-
tion of the ACC alters animals' avoidance responses using
the modified noxious hot-plate escape test. In this test,
mice learn to escape the noxious area by moving into an
unheated area. In the first trail, mice found the escape
route to the unheated area within 79.6 ± 17.7 sec after
being placed on the 50°C hot-plate, (n = 7 mice, Fig. 7a).
After repetitive training (n = 3 in total, with a 10 min inter-
val), mice learned to move into the 'safe' area within a sig-
nificantly shorter period of time (12.1 ± 1.8 sec; P < 0.01
compared with the first measurement). Furthermore, at
24 hours after training, mice quickly moved into the safe
area within a similar time (mean 8.1 ± 1.8 sec, n = 7 mice;
Fig. 7b). Next, we wanted to test if activation of the ACC
may affect behavioral escape responses. tACPD (0.25 µg
in 0.5 µl) was microinjected into the ACC before the train-
ing. While the escape time at the first trial was not signifi-
cantly affected by tACPD microinjection (n = 7 mice,
mean 70.1 ± 8.0 sec), mice moved into the safe area
within a significantly shorter period of time during the
second and third trials (P < 0.01 as compared with control
mice). Furthermore, at 24 hours after the training, mice
moved into the safe area significantly faster than control
mice (P < 0.05, Fig. 7b). To determine if the effects of
tACPD may affect subsequent extinction, we repetitively
exposed both groups of mice to the same plate at room
temperature (22°C) at 30 min intervals. Mice spent signif-
icantly longer time in the plate after learning that the plate
was not hot or noxious (n = 7 mice; Fig. 7c). As shown in
Fig. 7c, both groups of animals showed similar 'learning'
responses. These results indicate that local activation of
mGluRs in the ACC selectively enhanced the learning
ability to avoid the noxious plate.
To examine the effects of microinjection of tACPD in the
ACC on behavioral nociceptive responses, we examined
the effects of chemical activation of mGluRs in the ACC
on the spinal nociceptive tail-flick reflex and the hot-plate
test in awake mice. Microinjection of tACPD into the ACC
produced facilitation of spinal tail-flick reflex (n = 7 mice;
Fig. 8b). Furthermore, the response latency in the hot-
ACC inactivation by a GABAA receptor agonist impairs fear memory by foot shock Figure 6
ACC inactivation by a GABAA receptor agonist impairs fear memory by foot shock. (a,b) Mice receiving muscimol 
microinjection (1 µg/µl, 0.5 µl/each side, n = 6 mice, black bars) into bilateral ACC 15 min before conditioning showed reduced 
auditory (a) and contextual (b) fear memory induced by classic foot shock conditioning). * P < 0.05 compared with the saline 
treated group (n = 6, open bars). (c) Microinjection sites in the ACC. Filled circles: muscimol group; open circles, saline group.Molecular Pain 2005, 1:6 http://www.molecularpain.com/content/1/1/6
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Activation of mGluRs in the ACC facilitated escaping behavioral responses in a hot-plate Figure 7
Activation of mGluRs in the ACC facilitated escaping behavioral responses in a hot-plate. (a) A diagram explain-
ing a new behavioural escape test using the modified hot-plate instrument. (b) Mice receiving tACPD microinjection into the 
unilateral ACC 10 min before training showed faster escape response. * P < 0.05 compared with the control group (n = 6 
mice, open squares). (c) Extinction responses in control and tACPD-treated groups were similar. MPE were calculated as: 
(response latency – baseline latency)/(180 – baseline latency). 100% MPE indicates that mouse stayed in the same plate for 3 
min without moving into the safe area.Molecular Pain 2005, 1:6 http://www.molecularpain.com/content/1/1/6
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Spinal serotonin receptors contribute to descending facilitatory modulation from the ACC Figure 8
Spinal serotonin receptors contribute to descending facilitatory modulation from the ACC. (a, b) Microinjection 
of tACPD (0.25 µg in 0.5 µl) in the ACC facilitated the hot-plate responses (a, i.e., reduced response latency) and spinal nocic-
eptive tail-flick reflex (b) in freely moving mice; (c, d) In freely moving (c) or anesthetized rats (d), tACPD microinjection in the 
ACC also facilitated the tail-flick reflex. Intrathecal injection of a serotonergic receptor antagonist methysergide (32.0 nmoles/
10 µl) at a dose that blocked descending facilitation also blocked the facilitation of the tail-flick reflex.(e) A model explaining 
the neuronal pathways, which contribute to ACC activation, produced fear memory and descending facilitatory modulation of 
spinal nociception.Molecular Pain 2005, 1:6 http://www.molecularpain.com/content/1/1/6
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plate test was also significantly reduced (n = 5 mice, Fig.
8a). These results consistently suggest that activation of
mGluRs in the ACC is able to facilitate or enhance behav-
ioral responses to noxious stimuli. Previous studies in
anesthetized rats demonstrate that descending facilitation
induced by electrical/chemical activation in the ACC
depend on central relays in the brainstem RVM [33].
Descending serotonergic systems originated from the
brainstem raphe nucleus as well as adjacent areas are
thought to be important for descending facilitation of spi-
nal nociceptive transmission and reflexes [34-37]. To
examine if spinal serotonergic receptors are required for
tACPD-induced facilitation, we directly injected a sero-
tonergic receptor antagonist into the spinal cord through
intrathecal catheters in freely moving adult rats. Similar to
adult mice, microinjection of tACPD into the ACC pro-
duced a significant reduction in the tail-flick responses
latencies in rats (n = 3 rats, mean 5.8 ± 0.8 sec vs 3.2 ± 0.1
sec, P < 0.01, paired t-test). Intrathecal administration of
methysergide at a dose of 32.0 nmoles (10 µl, i.th.) that
blocked descending facilitatory effects from the RVM [34]
completely abolished the facilitation induced by tACPD
in the ACC (n = 3 rats; Fig. 8c). To avoid possible side
effects of stress, we also performed experiments in anes-
thetized rats. As reported previously [33], microinjection
of tACPD produced significant facilitation of the tail-flick
response latency in rats (n = 4 rats, mean 6.3 ± 0.3 sec vs
5.3 ± 0.5 sec, P < 0.05; Fig. 8d). Methysergide (32.0
nmoles/10 µl) injected intrathecally blocked the facilita-
tory effects produced by tACPD in the ACC (n = 4 mice,
Fig. 8d). These results consistently indicate that activation
of the ACC causes facilitation or anti-analgesic effects in
case of noxious stimulation.
What about the possibility that synaptic transmission
within the ACC may contribute to memory formation as
those reported in the amygdala? We suspect that synaptic
changes between two sides of the ACC connected by cal-
losal projection fibers may serve as an ideal candidate for
the storage of such information, since the thalamic-corti-
cal connections are important for ascending nociceptive
sensory transmission. In order to detect possible changes
in the ACC, we performed recordings of synaptic
responses in the ACC before and after fear conditioning.
As shown in Fig. 9, we found that synaptic responses to
stimulation of the callosal projection fibers from the other
side of the ACC were not affected by fear conditioning (n
= 5 mice). Furthermore, measurements of the same
responses at one day and 3 days after fear conditioning
also did not reveal any significant changes (Fig. 9), indi-
cating that synaptic transmission between the ACCs did
not undergo synaptic potentiation after fear conditioning.
To test if synaptic transmission may undergo potentiation
by theta burst stimulation, we also tested responses in
freely moving mice after applying theta burst stimulation
(TBS) locally into the ACC (n = 3 mice). As shown in Fig.
9, we found that synaptic transmission was enhanced for
the initial 3 hours.
Discussion
We present strong evidence that the ACC serves as a criti-
cal region for pain unpleasantness in the brains of adult
mice. Our results are consistent with previous reports
from human imaging that show that ACC is important for
pain affect or unpleasantness [2,3,5]. Clinical reports
show that lesions in the human ACC selectively influence
the unpleasant component of pain [9,10]. In animals,
lesions in the ACC blocked formalin-induced conditioned
place avoidance [26]. Both animal and human studies
indicate that neurons in the ACC respond to peripheral
painful stimuli or electric shocks [6,28], and injury trig-
gered activation of immediate early genes in the ACC
[27,29]. Unlike neurons in the somatosensory cortex,
neurons in the ACC tend to have widely diffuse receptive
fields, and often contain the whole body of animals,
supporting its role in coding unpleasantness of pain. Our
results using fear memory to measure pain triggered by
ACC stimulation avoid the possible contribution of
descending modulation to commonly used behavioural
nociceptive responses [33-37]. The present study provides
a new approach to study the role of pain in higher brain
function.
The ACC is a complex and heterogeneous cortex. Neuro-
physiological recordings, neuropsychological tests and
human imaging studies suggest that the ACC plays a key
role in cognitive control and is involved in response con-
flict monitoring [12,14,19]. The ACC may be involved in
the neural representation of motivational drives,
including sexual desire, hunger and the motivational
aspect of pain [13,22]. However, synaptic and molecular
mechanisms of the ACC in these higher order functions
are largely unknown, due to the lack of animal models.
The different roles of the ACC in various functions require
caution when explaining the current results. One possible
explanation is that ACC neurons express pain affect, gen-
eral unpleasantness, aspects of cognition and motor
response, and pain analgesia. These different functions
might be topographically organized along the extent of
the ACC, and through its potential interactions with other
cortical areas. Furthermore, possible differences between
mouse and human brains certainly contribute to some of
the different reports on the functions of human ACC vs
mice as presented here. For example, Shidara and Rich-
mond [15] reported that neural activity in the ACC codes
the degree of reward expectancy [15]. It is unclear if any of
those neurons are also involved in encoding pain unpleas-
antness. Due to the important role of the ACC in attention
and anticipation, another possibility is that ACC stimula-
tion alters learning by affecting such processes.Molecular Pain 2005, 1:6 http://www.molecularpain.com/content/1/1/6
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Fear conditioning did not cause long-term plasticity in ACC-ACC synapses Figure 9
Fear conditioning did not cause long-term plasticity in ACC-ACC synapses. (a) Evoked fast responses in the ACC 
by stimulation applied to the other side of ACC were not affected by single foot shock that induced classic fear memory. How-
ever, TBS induced synaptic potentiation in the ACC. Insets: Traces of evoked responses before, 3 hour, 1 day and 3 days after 
fear conditioning.(b) Summarized data of experiments shown in (a) and mice receiving the treatment without the foot shock (n 
= 2 mice).Molecular Pain 2005, 1:6 http://www.molecularpain.com/content/1/1/6
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Specifically, the ACC stimulation produces some anticipa-
tory "state" for unpleasantness rather than one of aversion
or unpleasantness. To test this possibility, we performed
experiments using a newly developed pain-related hot-
plate escaping test. Chemical activation of excitatory
mGluRs in the ACC enhanced the escape responses. These
results suggest that enhanced escape responses and behav-
ioural freezing responses are most likely due to pain-
related unpleasantness, and are unlikely to be explained
by simply the cessation of activity or goal directed activity.
It is also possible that ACC stimulation only causes pain,
and the unpleasantness is coded in other regions of the
brain. For fear memory, the projection from the ACC to
the amygdala plays an important role. Future experiments
are clearly needed to address these possibilities. Interest-
ingly, a recent study from Johansen and Fields [53]
showed that excitatory amino acid microinjection into the
ACC in rats during conditioning produced avoidance
learning in the absence of a peripheral noxious stimulus.
These findings indicate that that neurons in the ACC of
adult rats and mice mediate both pain-induced negative
affect and a nociceptive aversive teaching signal (see [53]).
Insular cortex has recently been shown to contribute to
pain perception [38,54]. It was shown that the insular cor-
tex may tonically control spinal nociceptive transmission
through descending inhibitory systems [54]. By contrast,
it has been reported that stimulation in the ACC produced
no antinociceptive effect, and facilitated spinal nocicep-
tive tail-flick reflex [33]. Inhibition of excitatory transmis-
sion in the ACC by microinjection of opioids produced
powerful analgesic effects in freely moving animals [25],
suggesting that the ACC is unique as a centre for
unpleasantness. Recent studies in knockout mice for ade-
nylyl cyclases1 and 8 as well as transgenic mice over
expressing NR2B receptors consistently indicate that
activity-dependent plastic signaling pathways in the ACC
may contribute to persistent pain, a classic condition with
long-term pain-related unpleasantness [29,30]. One pos-
sibility is that ACC stimulation may activate endogenous
analgesia from the ACC, in the absence of nociception,
might itself be aversive. To test this possibility, we per-
formed experiments in awake mice and rats using the spi-
nal nociceptive tail-flick reflex, a classic behavioural test
for endogenous analgesic/antinociceptive systems [33].
Activation of mGluRs in the ACC by tACPD actually facil-
itated behavioural responses in both the tail-flick reflex
and hot-plate tests, providing direct evidence that endog-
enous facilitatory but not inhibitory systems are activated.
Moreover, intrathecal injection of a serotonergic receptor
antagonist methysergide that blocked descending facilita-
tory modulation from the RVM [34,38] completely
blocked the facilitatory effects in awakened or anaesthe-
tized rats. These findings thus provide the first evidence,
to our knowledge, in freely moving animals, excitatory
activity in the ACC exert descending facilitatory modula-
tion on spinal nociception
Experiments using lesions in the central nervous system
provide important evidence for the involvement of certain
structures in learning and memory [55]. However, when
using the lesion technique it is difficult to distinguish
between roles of the ACC in the expression of freezing
responses, or the formation of fear memory. In the present
study, we performed a reversible blockade of ACC activity
during fear conditioning and found that fear memory was
blocked. Our results indicate that the blockade of fear
memory is not simply due to the ACC-dependent expres-
sion of freezing. One possible mechanism for the roles of
the ACC in fear memory is that inputs from the ACC feed-
back to the amygdala for the formation of fearful mem-
ory. Indeed, many ACC neurons directly project to the
amygdala [56,57]. We found that auditory fear memory
induced by pairing the ACC stimulation with a tone was
blocked by bilateral injection of the NMDA receptor
antagonist AP-5 into the amygdala. Contextual memory
was not significantly affected, suggesting that other struc-
tures may be involved or required for the expression of
contextual fear memory [55]. Our results provide new evi-
dence that cortical input from the ACC (coding unpleas-
antness) is critical for the formation of fear memory (see
Fig. 7e). Due to limitations of the microinjection tech-
nique, we cannot completely rule out the possible diffu-
sion of AP-5 into other nuclei within the amygdala.
Finally, we believe that mouse genetic models will pro-
vide ample opportunities for us to explore the molecular
mechanisms for high-order brain functions in experimen-
tal conditions. Together with imaging and electrophysio-
logical studies in humans and primates, we hope to reveal
new central and molecular targets for the treatment of
central pain, phantom pain and the unpleasantness
related to various mental disorders.
Methods
Animals
Animals were adult male C57BL6/J mice or Sprague-Daw-
ley albino rats that were housed individually and main-
tained on a 12/12 h light/dark cycle. Food and water were
provided ad libitum.
Brain electrode and microinjection cannula implantation
Animals were anesthetized with sodium pentobarbital
(80 mg/kg, i.p.) and implanted unilaterally with a
tungsten electrode in the ACC (0.62 mm anterior, 0.4 mm
lateral and 1.7 mm ventral to the Bregma) or S1 (0.62 mm
anterior, 2.8 mm lateral and 2.3 mm ventral to the
Bregma) [58] under aseptic conditions. The tungsten wire
extended 0.1–0.2 mm of the guide cannula that was used
as a reference. Mice were allowed to recover for 2 weeks
before the experiments. In preliminary experiments, weMolecular Pain 2005, 1:6 http://www.molecularpain.com/content/1/1/6
Page 14 of 16
(page number not for citation purposes)
performed several experiments to locate electrodes into
the mouse ACC. All procedures were in accordance with
the Animal Studies Committee at the University of
Toronto. At the end of the experiment, using standard his-
tological methods, 30 µm brain sections were stained with
cresyl violet and examined by light microscopy for elec-
trode placements or cannula penetrations. We only used
animals with stable implantation of electrodes that did
not exhibit abnormal behaviour during surgical recovery.
Results from stimulation sites outside of the ACC were not
used in the current studies.
Behavioral conditioning
On the day of conditioning, the electrode assembly was
connected to the stimulating hardware under brief isoflu-
rane sedation. Mice were allowed 5 min to recover and
habituate in the mouse conditioning chamber located in
a sound-attenuating box (Med Associates). A commutator
(CRIST INSTRUMENT CO.) was used to handle the con-
necting wires while mice were moving. Each mouse
received 3 pairings of training with 1 min in between. The
conditioned stimulus (CS) was a tone (2.8 kHz, 85 dB
sound pressure level, 30 s), and the unconditioned stimu-
lus (US) was the 10 s ACC stimulation that co-terminated
with the tone. The electrical stimulation parameters are as
following: 0.3 mA, 0.2 ms pulse duration, 5 pulses at 100
Hz per train, 200 ms train interval. 1 hour, 1 day and 3
days later, animals were first exposed to the conditioning
context without tone for 3 min and then to a novel con-
text without tone for 3 min followed by 3 min with tone
presentation. Freezing responses was scored visually and
presented as percentage of the total period of time
observed [31]. Baseline responses were subtracted in
order to evaluate responses to the context or tone. For the
unpaired training, tone and ACC stimulation were
delivered randomly with 40 s – 80 s interval. In some
experiments, tACPD (0.25 µg in 0.5 µl) was injected into
the ACC unilaterally. After the injection, mice were placed
in the conditioning chamber. Each mouse received a tone
(see above) for 10 min (at 0–5 and 10–15 min after the
tACPD injection).
Pharmacological treatment
Under anesthesia of sodium pentobarbital (80 mg/kg),
25-gauge guide cannulas were implanted bilaterally into
the ACC (0.62 mm anterior to Bregma, 0.5 mm lateral
from the midline, 0.9 mm beneath to the surface of the
skull) or BLAC (1.94 mm anterior to Bregma, 3.5 mm lat-
eral from the midline, 4.2 mm beneath to the surface of
the skull). Mice were given at least 2 weeks for recovery
after cannula implantation. 30-gauge injection cannula
was 0.8 mm lower than the guide. For intra-ACC infusion,
0.5 µl muscimol (1 µg/µl) or saline was delivered bilater-
ally within 90 s using a pump. 15 min later mice were con-
ditioned by 1 pairing of a tone (2.8 kHz, 85 dB, 30 s) and
a foot shock (0.75 mA, 2 s) that terminated simultane-
ously with the tone. For intra-BLAC infusion, 0.5 µl AP5
(2 µg/µl) or saline was delivered bilaterally within 90 s. 15
min later mice received 3 pairings of tone and ACC stim-
ulation, exactly as above.
Hot-plate escape test-a new behavioral test
Adult mice were trained using a modified thermal hot-
plate (10" × 10" heating surface) (Columbus Instruments,
Columbus) maintained at 50°C, with an escapable non-
thermal platform (8" × 5.5" surface). During the first
training trial, the escape platform was blocked until the
mice showed signs of nociception (e.g., licking of the hind
paws). The escape route was then unblocked, and the
mice were then free to explore both platforms. The first
time entry to the escape platform was recorded. The total
duration of each training trial was 3 min. Mice were
returned to the same modified thermal hotplate one day
after training, with the escape route remaining open, and
the temperature set at a room temperature of 22°C. The
first time entry to the escape platform was recorded, and
the mice were returned back to their home cage upon
escape. The maximum test time was 3 min. Mice were
tested a total of eight times with an inter-trial interval of
30 min. Mice that remained on the hotplate for the total
test duration were recorded with having an escape time of
3 min.
Spinal nociceptive tail-flick reflex
Mice or rats were used either in the awake or halothane-
anesthetized states. The spinal nociceptive tail-flick reflex
was evoked by noxious radiant heat provided by a 50 W
projector lamp focused on a 1.5 × 10 mm area on the
underside of the tail. The latency to reflexive removal of
the tail from the heat was measured by a digital photocell
timer to the nearest 0.1 s. Baseline TF latency was the
mean of 3 trials taken at 3 min intervals. For experiments
using anesthesia, rats were anesthetized with 2–3%
halothane (Ohio Medical Products) delivered via a spe-
cialized gas adapter (Stoleting Instrument; IL) with 30%
O2 balanced with nitrogen. Body temperature was main-
tained at 37 ± 0.5°C by a circulating water, thermostati-
cally-controlled heating pad.
Chemical microinjection into the ACC
A mGluR agonist, trans-(±)-1-amino-(1S, 3R)-cyclopen-
tanedicarboxylic acid (tACPD), was microinjected into
the ACC in a volume of 0.5 µl via an injection cannula
(33-gauge, 0.20 mm O.D.) inserted through the 26-gauge
guide cannula and also extending 2 mm beyond its tip.
Injection of tACPD was monitored by following the
movement of an air bubble in a length of calibrated tub-
ing between the syringe and the cannula.Molecular Pain 2005, 1:6 http://www.molecularpain.com/content/1/1/6
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Intrathecal drug injection
Intrathecal catheters (PE-10 tubing, 8.5 cm in length)
were inserted through a small opening in the cisterna
magna and extended to the lumbar subarachnoid space.
In case of experiments in freely moving rats, animals were
recovered for at least two weeks before the testing. Intrath-
ecal drug administration was done in the awake or haloth-
ane-anesthetized rats. In rats with ACC drug
microinjection, baseline TF latencies were determined at
3, 6 and 9 min before and after tACPD injection. After
observing the facilitatory effects at 10 min after the injec-
tion, methysergide or saline were injected intrathecally to
examine if the facilitatory effects may be blocked. The
selection of methysergide and dose used are based on pre-
vious studies of descending facilitatory modulation from
the RVM to the spinal cord [33,38].
Electrophysiological recordings in freely moving mice
Mice were anesthetized with sodium pentobarbital (80
mg/kg, i.p.). A concentric stimulating electrode was posi-
tioned in the right ACC and another concentric recording
electrode was placed to the left ACC (both were in Cg2).
Dental cement was used to keep the electrodes in place for
the recordings of field potential in freely moving mice.
Following surgery, mice were allowed to recovery for at
least two weeks. Test responses were elicited by monopha-
sic stimuli (200 µs, 75–190 µA, 1/60 s) at an intensity that
evoked 40–50% of the maximal responses. fEPSP potenti-
ation is expressed as percentage change relative to the
mean baseline response during the 30 min prior to the
single footshock stimulation.
Data analysis
Data are presented as mean ± 1 standard error of mean
(S.E.M). Facilitation of the TF reflex or hot-plate test is pre-
sented as a percentage of the control TF latency. Results
were expressed as mean ± s.e.m. One-way ANOVA or two-
way ANOVA with repeated measurements was used to
compare the differences between treatments. If not stated
otherwise, post-hoc comparisons were made with Tukey
test. In all cases, p < 0.05 was considered statistically
significant.
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